Scientific Program
Download a detailed version of the program
PLENARY LECTURES
| PL01 | HAV and HEV: Epidemiology, Virology, Immunology, Natural History, Vaccines, Treatment |
| PL02 | Epidemiology of HBV, HDV and HCV |
| PL03 | HCV: Virology, Immunology, Natural History, Treatment |
| PL04 | HBV and HDV: Virology, Immunology, Natural History, Treatment |
| PL05 | Late Breakers/Controversies and perspectives |
| PL06 | Hepatitis A and B vaccination and public health |
ANRS-ISVHLD Joint Venture meeting on Hepatitis and HIV Co-Infections
Wednesday July 5th, 2006, 10:30 to 18:00
Free registration compulsory on this website. Please fill in the registration form
See detailed program
PARALLEL SESSIONS
| PS01 | Hepatitis delta |
| PS02 | Vaccines and immune response |
| PS03 | HBV: Animal and cellular models |
| PS04 | Blood born viruses, blood transfusion, organ transplantation |
| PS05 | HAV & HEV: Basic research, development of new vaccines |
| PS06 | Molecular and clinical HBV epidemiology |
| (Sponsored by Bristol Myers Squibb) |
| PS07 | HBV: Clinical trials |
| PS08 | HCV: Animal and cellular models |
| PS09 | HBV: Immunopathogenesis and natural history |
| PS10 | HCV: Combination therapy |
| (Sponsored by Schering-Plough) |
| PS11 | HBV: Viral resistance |
| PS12 | HCV: New therapeutic approaches |
| PS13 | HCV: Carcinogenesis |
| PS14 | HBV/HCV: Viral kinetics |
| PS15 | HCV: Lymphomas, extra hepatic manifestations |
| PS16 | HBV/HCV: New therapeutic approaches/immunotherapy |
| PS17 | HBV replication and host-cell interactions |
| PS18 | Genetic Diversity and Diagnostic Testing in HBV and HCV Infections |
| PS19 | Geographical diversity |
| PS20 | HCV: Treatment failures |
| (Sponsored by Schering-Plough) |
| PS21 | HBV: Carcinogenesis |
| PS22 | Viral cellular interactions |
| PS23 | HCV: Epidemiology |
| PS24 | HBV/HCV: Hepatocellular carcinoma |
| PS25 | HCV: Clinical trials |
| PS26 | HBV: Mutants |
| PS27 | HCV particles and replication cycle |
| PS28 | HBV/HCV: Chronic liver failure and transplantation |
| PS29 | HBV - New antivirals |
| PS30 | HCV: Immunopathogenesis: cellular, humoral and innate response |
| PS31 | HCV replication and host-cell interactions |
| PS32 | Late breakers |
POST-GRADUATE COURSE
PG1 - Registration compulsory
Extending the Boundaries of Antiviral treatment
for Hepatitis B and C
Saturday July 1st 2006, 8:30 to 12:30
Organizers: G. Dusheiko (UK), F. Zoulim (France)
See detailed program
PG2 - Free Registration upon request to the Congress Office isvhld2006@mci-group.com
Courtesy of an unrestricted grant by Roche
HCV infection: The New Metabolic Frontier
Saturday July 1st 2006, 8:00 to 13:00
Organizers: L. Serfaty (France), Vlad Ratziu (France)
See detailed program
MEET THE PROFESSOR BREAKFASTS
Registration to the Meet the Professor Breakfasts is subject to the settlement of a 60 € fee.
MPB01: sponsored by Vertex Pharmaceuticals
Future HCV Therapies - Transforming the Treatment Paradigm
Sunday July 2nd 2006, 7:00 - 8:00
Chairpersons: A. Alberti (Italy), M. Manns (Germany)
MPB03: sponsored by Minophagen Pharmaceutical Co., Ltd., Japan
Prevention of Hepatocellular Carcinoma in Chronic Hepatitis Patients
with Anti-viral and/or Alternative Medicines
Monday July 3rd, 2006, 7:00 - 8:00
Chairpersons: M. Omata (Japan), SW. Schalm (The Netherlands)
MPB05: sponsored by GSK
Tuesday July 4th, 2006, 7:00 - 8:00
Title to be announced
SATELLITE SYMPOSIA
SS01: Satellite Symposium sponsored by Schering-Plough
Saturday July 1, 2006 from 14:00 to 15:30
Clinical Pathways Toward an Ideal HCV Therapy
SS02: Satellite Symposium sponsored by Bristol-Myers Squibb
Saturday July 1, 2006 from 16:00 to 17:30
From Hope to Action : Emerging strategies in the management of CHB
SS03: Satellite Symposium sponsored by Gilead
Sunday July 2, 2006 from 18:00 to 19:30
New HBV Data: What do we do now? - Practical Insights
SS04: Satellite Symposium sponsored by Vertex Pharmaceuticals Incorporated
Sunday July 2, 2006 from 18:00 to 19:30
Transforming Anti-HCV Treatment: The Potential for Specifically Targeted Antiviral Therapy for HCV (STAT-C)
SS05: Satellite Symposium sponsored by Idenix / Novartis
Monday July 3, 2006 from 18:00 to 19:30
The way forward in HCV treatment - finding the right path
SS06 : Satellite symposium sponsored by Chiron
Monday July 3, 2006 from 18:00 to 19:30
Occult Hepatitis B - Diagnosis and Pathogenesis
FREE ORAL COMMUNICATIONS & POSTER SESSIONS
Free oral communications will be presented during parallel sessions.
Poster viewing is scheduled during lunch breaks.
DETAILED SCIENTIFIC PROGRAM
Detailed program
|
